Stable expression and pharmacological properties of the human alpha 7 nicotinic acetylcholine receptor. 1995

M Gopalakrishnan, and B Buisson, and E Touma, and T Giordano, and J E Campbell, and I C Hu, and D Donnelly-Roberts, and S P Arneric, and D Bertrand, and J P Sullivan
Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, IL 60064-3500, USA.

The alpha 7 neuronal nicotinic acetylcholine receptor subtype forms a Ca(2+)-permeable homooligomeric ion channel sensitive to alpha-bungarotoxin in Xenopus oocytes. In this study, we have stably and functionally expressed the human alpha 7 cDNA in a mammalian cell line, HEK-293 and examined its pharmacologic properties. [125I] alpha-Bungarotoxin bound to transfected cells with a Kd value of 0.7 nM and a Bmax value of 973 pmoL/mg protein. No specific binding was detected in untransfected cells. Specific binding could be displaced by unlabeled alpha-bungarotoxin (Ki = 0.5 nM) and an excellent correlation was observed between binding affinities of a series of nicotinic cholinergic ligands in transfected cells and those in the human neuroblastoma IMR-32 cell line. Additionally, cell surface expression of alpha 7 receptors was detected by fluorescein isothiocyanate-conjugated alpha-bungarotoxin in transfected cells. Whole cell currents sensitive to blockade by alpha-bungarotoxin, and with fast kinetics of activation and inactivation, were recorded from transfected cells upon rapid application of (-)-nicotine or acetylcholine with EC50 values of 49 microM and 155 microM respectively. We conclude that the human alpha 7 subunit when expressed alone can form functional ion channels and that the stably transfected HEK-293 cell line serves as a unique system for studying human alpha 7 nicotinic receptor function and regulation, and for examining ligand interactions.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009538 Nicotine Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke. Nicotine Bitartrate,Nicotine Tartrate
D011978 Receptors, Nicotinic One of the two major classes of cholinergic receptors. Nicotinic receptors were originally distinguished by their preference for NICOTINE over MUSCARINE. They are generally divided into muscle-type and neuronal-type (previously ganglionic) based on pharmacology, and subunit composition of the receptors. Nicotinic Acetylcholine Receptors,Nicotinic Receptors,Nicotinic Acetylcholine Receptor,Nicotinic Receptor,Acetylcholine Receptor, Nicotinic,Acetylcholine Receptors, Nicotinic,Receptor, Nicotinic,Receptor, Nicotinic Acetylcholine,Receptors, Nicotinic Acetylcholine
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002038 Bungarotoxins Neurotoxic proteins from the venom of the banded or Formosan krait (Bungarus multicinctus, an elapid snake). alpha-Bungarotoxin blocks nicotinic acetylcholine receptors and has been used to isolate and study them; beta- and gamma-bungarotoxins act presynaptically causing acetylcholine release and depletion. Both alpha and beta forms have been characterized, the alpha being similar to the large, long or Type II neurotoxins from other elapid venoms. alpha-Bungarotoxin,beta-Bungarotoxin,kappa-Bungarotoxin,alpha Bungarotoxin,beta Bungarotoxin,kappa Bungarotoxin
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004594 Electrophysiology The study of the generation and behavior of electrical charges in living organisms particularly the nervous system and the effects of electricity on living organisms.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Gopalakrishnan, and B Buisson, and E Touma, and T Giordano, and J E Campbell, and I C Hu, and D Donnelly-Roberts, and S P Arneric, and D Bertrand, and J P Sullivan
January 1996, The Journal of pharmacology and experimental therapeutics,
M Gopalakrishnan, and B Buisson, and E Touma, and T Giordano, and J E Campbell, and I C Hu, and D Donnelly-Roberts, and S P Arneric, and D Bertrand, and J P Sullivan
June 1995, Neuropharmacology,
M Gopalakrishnan, and B Buisson, and E Touma, and T Giordano, and J E Campbell, and I C Hu, and D Donnelly-Roberts, and S P Arneric, and D Bertrand, and J P Sullivan
May 2000, The Journal of biological chemistry,
M Gopalakrishnan, and B Buisson, and E Touma, and T Giordano, and J E Campbell, and I C Hu, and D Donnelly-Roberts, and S P Arneric, and D Bertrand, and J P Sullivan
April 1996, Neuropharmacology,
M Gopalakrishnan, and B Buisson, and E Touma, and T Giordano, and J E Campbell, and I C Hu, and D Donnelly-Roberts, and S P Arneric, and D Bertrand, and J P Sullivan
May 1997, Cellular and molecular biology (Noisy-le-Grand, France),
M Gopalakrishnan, and B Buisson, and E Touma, and T Giordano, and J E Campbell, and I C Hu, and D Donnelly-Roberts, and S P Arneric, and D Bertrand, and J P Sullivan
November 1993, Nucleic acids research,
M Gopalakrishnan, and B Buisson, and E Touma, and T Giordano, and J E Campbell, and I C Hu, and D Donnelly-Roberts, and S P Arneric, and D Bertrand, and J P Sullivan
September 2009, Life sciences,
M Gopalakrishnan, and B Buisson, and E Touma, and T Giordano, and J E Campbell, and I C Hu, and D Donnelly-Roberts, and S P Arneric, and D Bertrand, and J P Sullivan
November 2010, Visual neuroscience,
M Gopalakrishnan, and B Buisson, and E Touma, and T Giordano, and J E Campbell, and I C Hu, and D Donnelly-Roberts, and S P Arneric, and D Bertrand, and J P Sullivan
January 2024, CNS & neurological disorders drug targets,
M Gopalakrishnan, and B Buisson, and E Touma, and T Giordano, and J E Campbell, and I C Hu, and D Donnelly-Roberts, and S P Arneric, and D Bertrand, and J P Sullivan
May 2011, British journal of pharmacology,
Copied contents to your clipboard!